Navigation Links
Obituary: Professor James Boyer Brown
Date:11/3/2009

MELBOURNE, Australia, Nov. 3 /PRNewswire/ -- The scientific and medical community mourns the loss of our esteemed colleague and good friend Emeritus Professor James Boyer Brown AM, MSc (NZ), PhD (Edin), MSc (Melb), DSc (Edin), FRANZCOG (Ad Eundem), Life Member Fertility Society of Australia, Life Member Endocrine Society of Australia, who passed away on Saturday 31st October 2009, aged 90.

Born 7 October 1919 in New Zealand and educated at Auckland University College (MSc - First Class Honours in chemistry), James Brown was manpowered to the laboratories at the Auckland Hospital early in the Second World War. He rationalised the sterilisation procedures at the hospital, qualified in bacteriology, haematology and histology and built up the biochemistry laboratory from some simple backroom tests to the type of facility that exists today. He also set up the blood bank, the monitoring of blood electrolytes and the production of sterile solutions for peritoneal lavage (the precursor of renal dialysis).

During the war, chemicals that were required for the new tests were often in short supply so he developed methods for synthesising or regenerating them, using techniques that often required innovative use of materials available. One example of his innovative skills was the production of ampoules of blood-typed sera for the Pacific forces using a home-made freezer. The ability to innovate was a skill that he used to great advantage right throughout his life and he was constantly searching for better ways of doing things.

After the war in 1947, he developed an interest in endocrinology and reproduction and started a small animal breeding surgery, set up bioassays for urinary gonadotrophins and oestrogen (the female hormone) and concluded that the most important requirement in human reproduction was the development of a highly accurate method for timing ovulation in women, similar to the phenomenon of oestrus in animals.
'/>"/>

SOURCE Ovulation Method Research and Reference Centre of Australia Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Expert on Emerging Infectious Zoonotic Diseases Joining K-State as a Regents Distinguished Professor
2. University of Iowa professor identifies new eating disorder
3. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
4. George Mason University professor receives $2.6 million NIH grant to study Alzheimers disease
5. N.J. nurses are overworked according to Rutgers College of Nursing professor
6. Rutgers College of Nursing emerita professor Beverly Whipple receives FSSS book award
7. Boston University School of Medicine Professor receives award from American Heart Association
8. Louisiana Tech professor is Small Times Innovator of the Year
9. Protalix BioTherapeutics Appoints Professor Roger D. Kornberg to Board of Directors
10. Whale music captivates NJIT Professor David Rothenberg for new book, CD
11. Danny Calegari Appointed the Richard Merkin Distinguished Professor of Mathematics at the California Institute of Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Human guinea pigs wary of high-paying medical trials 2
... care visits to family doctors are declining, rese...Day News) -- Specialists are increasingly providin...ionally been handled by primary care doctors, a ne... visits for specialized care is for routine and pr...
... Workman proudly touts support of Sam Schmidt Para... While Punch Energy Drink,s well-recognized tagli...orkman, Punch Energy Founder and 21-year-old bever...oday, Workman proudly announced that the Sam Schmi...
...leadership needed to manage growth , , WAYNE, Pa....f clinical documentation software, workflow tools ...and realigning its organization by service and sol...ion Services and James Stewart, Vice President of ...
..., March 10 More physician leaders are embracing t...records, but most still consider them clunky and u...ults found in a recent survey by the American Coll... management. , , ACPE conducted the same survey b...
... March 10 LCA-Vision Inc. (Nasdaq: LCAV ) today...arison of excimer laser platform technologies, the...of platforms at each of its Lasik Plus (R) vision ...ly no later than the end of the third quarter of 2...
...arch 10, 2009 Forest Laboratories, Inc. (NYSE: ...rma GmbH & Co. KGaA, and Merz Pharmaceuticals ...emark Office has issued a Notice of Final Determin... Administration Orange Book for NAMENDA(R) (memant...
Other Medicine News:Health News:For Primary Care, More Patients Are Seeing Specialists 2Health News:For Primary Care, More Patients Are Seeing Specialists 3Health News:Punch Energy Drink Announces Recipient of Its Inaugural LIVE BETTER AWARD(R) 2Health News:Punch Energy Drink Announces Recipient of Its Inaugural LIVE BETTER AWARD(R) 3Health News:Precyse Solutions Adds Executives, Realigns Around Service Lines 2Health News:Survey Results: Health Care Technology Advances as Physician Frustration Grows 2Health News:LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually 2Health News:LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually 3Health News:LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually 4Health News:USPTO Issues Notice of Final Determination for Patent Term Extension for NAMENDA(R) 2
(Date:12/3/2009)MADISON, N.J., Dec. 3 A genetic variation that may indicate a patient,s risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is
(Date:12/3/2009)DOYLESTOWN, Pa., Dec. 3 Ted Karkus, Chairman and CEO of The Quigley Corporation, (Nasdaq: QGLY ) www.quigleyco.com announced today that the Company has completed its evaluation of its opportunitie
(Date:12/3/2009)WARRENDALE, Pa., Dec. 3 Radiology imaging leader MEDRAD, Inc. demonstrated PACS* injection-record integration capabilities at the November 2009 Radiology Society of North America in Chicago. The Co
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Echo Therapeutics Announces Significant Advance in Development of its One Piece Needle Free Symphony tCGM Biosensor 5825 1Echo Therapeutics Announces Significant Advance in Development of its One Piece Needle Free Symphony tCGM Biosensor 5825 2Echo Therapeutics Announces Significant Advance in Development of its One Piece Needle Free Symphony tCGM Biosensor 5825 3Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 1Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 2Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 3Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 4Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 5Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 6Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 7Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 8Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 9Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 10Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 11Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 12Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 13Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 14Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 15Dr Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics 5815 1Dr Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics 5815 2Dr Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics 5815 3
...S, Oct. 26 The complex cases performed,during thi... Therapeutics,symposium by Dr. Tony Das, an interv...Dallas, represent the latest treatments for periph... the U.S. population ages and more,Americans live ... will also,dramatically increase the number of peo...
...SLEY, Mass., Oct. 26 Coley,Pharmaceutical Group, ...mpany,has received a $3.0 million milestone paymen...nitiation of GSK,s Phase III clinical trial in,non...eutic cancer vaccine,containing Coley,s VaxImmune(... the launch of the largest Phase III,clinical tria...
Other Medicine Technology:Cardiologists Tackle 'Next Frontier' in Cardiovascular Disease 2Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline 2Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline 3
High Lite Convertible
High Lite Classic
High Beam Classic
...nalyzer is a semi-automated benchtop instrument fo...nQuick is designed to analyze and generate results...k 8+ urine test strips. The UrinQuick analyzes the...y. Test results are available in conventional, S.I...
Medicine Products: